| Economía y salud J Frenk, R Lozano, MA González-Block México, DF: Fundación Mexicana para la Salud, 1994 | 317* | 1994 |
| Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy S Barquera, I Campos-Nonato, C Aguilar-Salinas, R Lopez-Ridaura, ... Globalization and health 9 (1), 3, 2013 | 297 | 2013 |
| Análisis y reflexión sobre modelos teóricos del proceso salud-enfermedad A Arredondo Cad Saúde Pública 8 (3), 254-81, 1992 | 235 | 1992 |
| Economic consequences of epidemiological changes in diabetes in middle-income countries the Mexican case A Arredondo, A Zúñiga Diabetes Care 27 (1), 104-109, 2004 | 219 | 2004 |
| Costos de la diabetes en Ameŕica latina: evidencias del caso mexicano A Arredondo, E De Icaza Value in health 14 (5), S85-S88, 2011 | 200 | 2011 |
| Modelos explicativos sobre la utilización de servicios de salud: revisión y análisis A Arredondo, V Meléndez Salud pública de México 34 (1), 36-49, 1992 | 163 | 1992 |
| Road traffic injuries in an urban area in Mexico: An epidemiological and cost analysis M Hı́jar, A Arredondo, C Carrillo, L Solórzano Accident Analysis & Prevention 36 (1), 37-42, 2004 | 106 | 2004 |
| Modelos conceptuales y paradigmas en salud pública C Hernández-Girón, E Orozco-Núñez, A Arredondo-López Revista de salud pública 14 (2), 315-324, 2012 | 105 | 2012 |
| The cost of diabetes in Latin America and the Caribbean in 2015: evidence for decision and policy makers A Barcelo, A Arredondo, A Gordillo–Tobar, J Segovia, A Qiang Journal of global health 7 (2), 2017 | 100 | 2017 |
| Health disparities from economic burden of diabetes in middle-income countries: evidence from México A Arredondo, G Reyes PloS one 8 (7), e68443, 2013 | 88 | 2013 |
| Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America A Arredondo, A Azar, AL Recamán Global public health 13 (7), 780-787, 2018 | 77 | 2018 |
| Prescripción, acceso y gasto en medicamentos entre usuarios de servicios de salud en México R Leyva-Flores, J Erviti-Erice, M de la Luz Kageyama-Escobar, ... Salud pública de México 40 (1), 24-31, 1998 | 74 | 1998 |
| Costs and Epidemiological Changes of Chronic Diseases: Implications and Challenges for Health Systems A Arredondo, R Aviles PloS one 10 (3), e0118611, 2015 | 69 | 2015 |
| Costo-efectividad de intervenciones para insuficiencia renal crónica terminal A Arredondo, R Rangel, E de Icaza Revista de Saúde Pública 32 (6), 556-565, 1998 | 68 | 1998 |
| Costos económicos en la producción de servicios de salud: del costo de los insumos al costo de manejo de caso A Arredondo, T Damián Salud pública de México 39 (2), 117-124, 1997 | 67 | 1997 |
| Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico A Arredondo, A Zuñiga, I Parada Public Health 119 (8), 711-720, 2005 | 64 | 2005 |
| Epidemiologic Changes and Economic Burden of Hypertension in Latin America Evidence from Mexico A Arredondo, A Zúñiga American journal of Hypertension 19 (6), 553-559, 2006 | 62 | 2006 |
| Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine A Arredondo BMC medicine 12 (1), 1, 2014 | 60 | 2014 |
| Determinants of performance of health systems concerning maternal and child health: A global approach CE Pinzón-Flórez, JA Fernández-Niño, M Ruiz-Rodríguez, ÁJ Idrovo, ... PloS one 10 (3), e0120747, 2015 | 58 | 2015 |
| Equity, governance and financing after health care reform: lessons from Mexico A Arredondo, E Orozco The International journal of health planning and management 23 (1), 37-49, 2008 | 56* | 2008 |
